Latest Capital Raises News

Hexima Limited reported a stable cash position of $1.55 million at quarter-end, with a modest $87,000 net cash outflow from operations. The biotech company continues to explore strategic opportunities while maintaining a strong funding runway.

Skin Elements Limited advances its natural biotechnology products with ECO-Nurture trials concluding and SuprCuvr disinfectant gaining traction, supported by a successful $656k capital raise.

Green Technology Metals (ASX: GT1) reports a significant lithium resource increase to 30.4 million tonnes and advances key projects in Ontario, while implementing strategic cost controls amid challenging market conditions.

Kalamazoo Resources progresses due diligence on its Ashburton Gold Project under De Grey’s $30 million option, reports significant metallurgical drilling intercepts, and raises $0.8 million post-quarter to support ongoing exploration.

UNITH Ltd reports a 9.3% rise in Q3 FY25 cash receipts driven by its B2C subscription surge and a landmark pharmaceutical contract, alongside strategic platform upgrades and leadership changes.

Kalamazoo Resources Limited reported a challenging quarter with ongoing negative cash flows but plans a $0.8 million capital raise to sustain its exploration activities.

Kore Potash has completed an Optimised Definitive Feasibility Study for its Kola Potash Project, outlining a $2.07 billion capital cost and a 23-year mine life. The company also secured $10.1 million in funding and holds $10.2 million in cash as it prepares for construction.

Carbine Resources Limited is making steady progress towards securing the mining lease for its high-grade Muchea West Silica Sand Project while continuing exploration activities at its Down South project. The company reported $76,000 in exploration expenditure and holds $262,000 in cash reserves as it plans further funding.

NSX Limited reported a net cash outflow from operations of AUD 1.3 million in Q3 2025 but is bolstering its liquidity through a new capital raising initiative to sustain ongoing activities.

Nimy Resources has defined a high-grade gallium Exploration Target in Western Australia and secured strategic partnerships to support supply to the US Department of Defense, positioning itself strongly in the critical minerals sector.

Chariot Corporation has bolstered its exploration portfolio with seven new lithium and gold tenement applications in Western Australia’s Southern Cross Greenstone Belt, alongside securing $600,000 through a convertible note facility and extending payment terms on its flagship Black Mountain project.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.